K.R.R. Drugs & Intermediates Private Limited, a active private limited company, was established on 30 January 2002 in Ameerpet, Hyderabad., Andhra Pradesh, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24239AP2002PTC038417. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹2.50 Cr and a paid-up capital of ₹2.50 M.
Formerly known as Medeva Laboratories Private Limited. It upholds a compliant status. Employing 6 professional, Its leadership includes Subbarao Kattamuri (Director), Sushma Kattamuri (Director). Past directors included Subbarao Kattamuri, Venkateswara Reddy Dronadula, Vamsi Krishna Vanteru. It holds no open charges and ₹15.43 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.406, Aditya Trade Centre,, Ameerpet, Hyderabad., Andhra Pradesh, 500038.
U24239AP2002PTC038417
038417
30 January 2002
₹2.50 Cr
₹2.50 M
Roc Vijayawada
Unlisted
Active
Explore comprehensive insights into K.R.R. Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subbarao Kattamuri | Director | 08 Jul 2015 | Current |
| Sushma Kattamuri | Director | 13 Aug 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 04 Jun 2015 | Past |
| Pramod Abcsdd | Whole-Time Director | 20 Dec 2023 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 17 Jun 2013 | Past |
| Pramod Abcsdd | Director | 04 Jun 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
K.R.R. Drugs & Intermediates Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 7.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 23.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to K.R.R. Drugs & Intermediates's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹154,318,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2014 | Syndicate Bank | ₹7.40 Cr | Satisfied |
| 01 Aug 2005 | Syndicate Bank | ₹2.75 Cr | Satisfied |
| 01 Aug 2005 | Syndicate Bank | ₹1.14 Cr | Satisfied |
| 08 Jun 2005 | Syndicate Bank | ₹1.31 Cr | Satisfied |
| 22 Mar 2004 | Central Bank Of India | ₹2.83 Cr | Satisfied |
Explore comprehensive loan charge details -
K.R.R. Drugs & Intermediates has a workforce of 6 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of K.R.R. Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped K.R.R. Drugs & Intermediates's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
K.R.R. Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Sushma Kattamuri was appointed as a Director was appointed as a Director on 13 Aug 2024 & has been associated with this company since 1 year 4 months . was recorded as a recent event.
The activity K.R.R. Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Vijayawada. was completed.
Progress on Subbarao Kattamuri was appointed as a Director was appointed as a Director on 08 Jul 2015 & has been associated with this company since 10 years 5 months . was documented.
The activity A charge registered on 04 Oct 2014 via Charge ID 10532574 with Syndicate Bank was fully satisfied on 02 Jun 2015. was completed.
A charge registered on 01 Aug 2005 via Charge ID 90133288 with Syndicate Bank was fully satisfied on 08 Jan 2015. was recorded as a recent event.
The CIN of K.R.R. Drugs & Intermediates Private Limited is U24239AP2002PTC038417.
K.R.R. Drugs & Intermediates Private Limited is headquartered at Flat No.406, Aditya Trade Centre,, Ameerpet, Hyderabad., Andhra Pradesh, 500038.
K.R.R. Drugs & Intermediates Private Limited was incorporated on 30 January 2002.
The current directors of K.R.R. Drugs & Intermediates Private Limited are
The primary industry of K.R.R. Drugs & Intermediates Private Limited is Manufacturing.
K.R.R. Drugs & Intermediates Private Limited is unlisted.
The authorized capital of K.R.R. Drugs & Intermediates Private Limited is ₹2.50 Cr, and the paid-up capital is ₹2.50 M.
The compliance status of K.R.R. Drugs & Intermediates Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX